Oruka Therapeutics, Inc. · NASDAQ:ORKA
Venrock Healthcare Capital Partners III, L.P. reported a 9.90% stake in Oruka Therapeutics, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Venrock Healthcare Capital Partners III, L.P. reported a 9.90% stake in Oruka Therapeutics, Inc., 4,909,619 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 9.90%
- Shares
- 4,909,619
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. | 9.90% | 4,909,619 |
| VHCP Co-Investment Holdings III, LLC | 9.90% | 4,909,619 |
| Venrock Healthcare Capital Partners EG, L.P. | 9.90% | 4,909,619 |
| VHCP Management III, LLC | 9.90% | 4,909,619 |
| VHCP Management EG, LLC | 9.90% | 4,909,619 |
| Nimish Shah | 9.90% | 4,909,619 |
| Bong Y. Koh | 9.90% | 4,909,619 |
Source
Related
- Oruka Therapeutics, Inc.
- Venrock Healthcare Capital Partners III, L.P.
- Oruka Therapeutics, Inc. shareholders
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Aug 14, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Feb 27, 2025
- Form 4 · Quinlan Paul T · Oct 20, 2026
- Form 4 · Goncalves Joana · Oct 15, 2026
- Form 4 · Agarwal Arjun · Oct 13, 2026
- Form 4 · Klein Lawrence Otto · Oct 2, 2026
- Form 4 · Quinlan Paul T · Sep 21, 2026